Frank Rimerman Advisors LLC lowered its holdings in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 54.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 11,252 shares of the company’s stock after selling 13,406 shares during the period. Frank Rimerman Advisors LLC’s holdings in Procter & Gamble were worth $1,613,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in the business. Brighton Jones LLC increased its stake in shares of Procter & Gamble by 51.5% in the 4th quarter. Brighton Jones LLC now owns 40,068 shares of the company’s stock valued at $6,717,000 after acquiring an additional 13,617 shares in the last quarter. Taylor Financial Group Inc. boosted its stake in Procter & Gamble by 10.6% during the first quarter. Taylor Financial Group Inc. now owns 2,891 shares of the company’s stock worth $493,000 after acquiring an additional 277 shares in the last quarter. Sivia Capital Partners LLC grew its holdings in Procter & Gamble by 19.8% in the second quarter. Sivia Capital Partners LLC now owns 6,144 shares of the company’s stock worth $979,000 after purchasing an additional 1,016 shares during the period. Auxano Advisors LLC grew its holdings in Procter & Gamble by 10.8% in the second quarter. Auxano Advisors LLC now owns 7,315 shares of the company’s stock worth $1,165,000 after purchasing an additional 714 shares during the period. Finally, Schnieders Capital Management LLC. increased its stake in Procter & Gamble by 2.8% in the second quarter. Schnieders Capital Management LLC. now owns 30,182 shares of the company’s stock valued at $4,809,000 after purchasing an additional 809 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.
Trending Headlines about Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Investors are rotating into defensive, dividend-rich consumer staples as recession odds rise, which supports demand for PG stock as a low-beta hedge. As Recession Odds Climb, Defensive Sectors Continue to Outperform (PG)
- Positive Sentiment: New OLAY peptide research was presented at a dermatology conference and P&G plans to integrate proprietary peptide technologies into product formulas—an R&D catalyst that could support premium pricing and brand value over time. OLAY Peptide Research Puts New Spotlight On Procter And Gamble Valuation
- Positive Sentiment: Recent session saw PG outperform the market on a prior close, reflecting investor preference for staples amid broader weakness. This shows defensive demand can provide near-term support. Procter & Gamble (PG) Ascends While Market Falls
- Neutral Sentiment: Analysts expect P&G’s upcoming fiscal Q3 results to show low single-digit EPS growth—this raises the bar modestly: a beat could lift the stock, while a slight miss may reinforce current caution. What to Expect From Procter & Gamble’s Next Quarterly Earnings Report
- Neutral Sentiment: Market commentary and analyst notes on consumer goods (including P&G and peers) are circulating, offering mixed takes that could influence near-term analyst revisions but contain no single decisive catalyst. Analysts Offer Insights on Consumer Goods Companies: Procter & Gamble (PG) and Costco (COST)
- Negative Sentiment: TD Cowen cut its price target to $142 from $156 and kept a Hold rating, citing oil-related input-cost inflation tied to geopolitical tensions—this analyst action puts downward pressure on sentiment and could limit near-term upside. TD Cowen Adjusts Price Target on Procter & Gamble to $142 from $156; Maintains Hold Rating
- Negative Sentiment: Reports say Deutsche Bank has lowered expectations for P&G, and coverage notes broadly point to cost pressures (including oil-related input inflation from Middle East tensions) that could compress margins if raw-material costs accelerate. Deutsche Bank Aktiengesellschaft Has Lowered Expectations for Procter & Gamble (NYSE:PG) Stock Price
- Negative Sentiment: Coverage summarizing analyst downgrades highlights Iran-war related cost risks and has contributed to recent negative headlines and downgrades that weigh on sentiment. Wall Street Downgrades Procter & Gamble Amid Iran War Cost Pressures and More
Analyst Ratings Changes
Procter & Gamble Stock Down 0.2%
Procter & Gamble stock opened at $144.19 on Thursday. The firm has a market capitalization of $335.10 billion, a price-to-earnings ratio of 21.36, a price-to-earnings-growth ratio of 5.08 and a beta of 0.41. The firm’s fifty day moving average price is $153.85 and its two-hundred day moving average price is $149.84. Procter & Gamble Company has a 1-year low of $137.62 and a 1-year high of $174.80. The company has a current ratio of 0.72, a quick ratio of 0.51 and a debt-to-equity ratio of 0.49.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its earnings results on Friday, January 23rd. The company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.86 by $0.02. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The company had revenue of $22.21 billion for the quarter, compared to analyst estimates of $22.36 billion. During the same quarter in the prior year, the business posted $1.88 EPS. The firm’s revenue was up 1.5% compared to the same quarter last year. On average, equities research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, February 17th. Stockholders of record on Friday, January 23rd were paid a $1.0568 dividend. The ex-dividend date of this dividend was Friday, January 23rd. This represents a $4.23 annualized dividend and a dividend yield of 2.9%. Procter & Gamble’s dividend payout ratio is 62.67%.
Insider Buying and Selling
In other news, Chairman Jon R. Moeller sold 162,232 shares of the firm’s stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $162.45, for a total value of $26,354,588.40. Following the transaction, the chairman owned 319,385 shares in the company, valued at $51,884,093.25. This trade represents a 33.68% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Marc S. Pritchard sold 95,903 shares of the company’s stock in a transaction on Friday, January 23rd. The stock was sold at an average price of $151.15, for a total value of $14,495,738.45. Following the sale, the insider owned 182,607 shares of the company’s stock, valued at $27,601,048.05. This trade represents a 34.43% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 348,618 shares of company stock valued at $55,462,643. 0.20% of the stock is currently owned by company insiders.
About Procter & Gamble
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
See Also
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
